Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Reinforced Cardiac Shunt Helps Repair Serious Heart Defect

By HospiMedica International staff writers
Posted on 07 Jul 2015
A new study shows that using a ring-reinforced shunt improves surgical outcomes in children born with hypoplastic left heart syndrome (HLHS).

Researchers at Boston Children’s Hospital (MA, USA) and Harvard Medical School (Boston, MA, USA) conducted a retrospective review of 87 patients with HLHS who underwent Norwood Stage-1 surgery. More...
Of these, 48 patients received the standard, non-reinforced Gore-Tex right-ventricle-to-pulmonary-artery (RV-PA) conduit, and 39 received the same conduit, but reinforced with rings. The -reinforced graft was placed through a limited ventriculotomy. Primary and secondary outcomes were survival and need for cardiac re-intervention up to age 12 months.

The results showed that a ring-reinforced conduit was associated with reduced intervention, as well as higher pulse pressures and improved pulmonary artery (PA) growth. There was no difference in transplant-free survival by age 12 months, but those with the non-reinforced grafts had more interventions during their first year (69% versus 35%, respectively). Survival to discharge after the first stage Norwood surgery was 98% in the ring-reinforced group, compared with 83% in the non-reinforced group. In addition, survival at 12 months was higher in the ring-reinforced group (92% versus 75%). The study was published in the June 2015 issue of the Journal of Thoracic and Cardiovascular Surgery.

“The technique of using a ring-reinforced graft in conjunction with a limited right ventricular incision has theoretic advantages in preserving right ventricular function,” said lead author Audrey Marshall, MD, of the department of cardiology. “The ring-reinforced conduit maintains a uniform interior passageway for blood flow.”

“Although avoiding the use of a non-reinforced conduit may seem to be a minor adjustment in technique, the potential for important long-term patient benefit cannot be disregarded,” said Charles Fraser Jr., MD, of Texas Children's Hospital (Houston, USA) in an editorial commentary. “While the journey toward staged HLHS palliation was begun several decades ago and there have been many steps, it remains an arduous journey. Even a small step of progress encourages further focus.”

HLHS is a congenital defect in which the left side of the heart does not develop properly, impairing normal circulation. Children with this condition undergo a series of three reconstructive surgeries, called the Norwood Procedure, to help restore oxygenated blood flow. The first stage attempts to permit the normally functioning right ventricle to pump blood to both the lungs and the body. The second stage, the Bi-directional Glenn Shunt Procedure, follows when the infant is between four and six months old. The third step is the Fontan Procedure, which is carried out between 18 months to three years of age. Since only about 50% of children survive this three-part surgical series after five years, surgeons are always looking for ways to improve outcomes.

Related Links:

Boston Children’s Hospital
Harvard Medical School



Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.